Top News
Breakingviews: AbbVie inversion in the Shire
Posted
Investors are unimpressed by AbbVie's sweetened offer for Shire. Rob Cyran and Rob Cox discuss the deal.
Top News
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up